Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089609
Status:
COMPLETED
Last Update Posted:
2018-04-20
First Post:
2004-08-06
Brief Title:
Docetaxel Thalidomide Prednisone and Bevacizumab to Treat Metastatic Prostate Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2004-08-06
First Submit QC Date:
August 6 2004
Study First Post Date:
2004-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-11-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-22
Last Update Post Date:
2018-04-20
Last Update Post Date Type:
ACTUAL